Objectives: This study aimed to detect α-and β-thalassaemia mutations in the Jino ethnic minority population of Yunnan Province, Southwest China.
INTRODUCTION
As a group of monogenic disorders, thalassaemia is a serious health problem worldwide, especially in Mediterranean areas, Southeast Asia and Southern China. [1] [2] [3] Yunnan Province, which is located along the border areas of China-Myanmar-Laos, is notable for its ethnic diversity. According to a previous study of children under 10 years of age, several ethnic minorities in this region have a high prevalence of thalassaemia, with the prevalence of α-thalassaemia (α-thal) being highest (22.1%) in Dai from Xishuangbanna and the prevalence of β-thalassaemia (β-thal) being highest in Achang (40.6%). 4 Jino is the last ethnic minority confirmed in China, and the prevalence of α-thal and β-thal among Jino children are 3.1% and 29.3%, respectively. Thalassaemic children may exhibit various clinical symptoms; some are asymptomatic carriers, whereas others have severe haemolytic anaemia. 5 Blood transfusion therapy, which is needed for severe carriers, imposes a heavy burden on families and public health management. 6 Although genetic screening is essential to prevent and control this inherited disease, systematic investigations of thalassaemia mutations in Jino adults are rare.
The Jino population comprises nearly 20 000 individuals, and most (∼90%) live around Jino Mountain, which is located in East-Central Yunnan Province. 7 A large number of thalassaemic mutations have been found in the general population worldwide; [8] [9] [10] however,
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little is known about this isolated population. Indeed, the molecular mechanism and genetic variations of thalassaemia in Jino individuals may be different from those in other ethnicities. Our study aimed to detect α-thal and β-thal gene mutations in Jino adults to provide basic information for further prenatal consulting and thalassaemia diagnosis. A total of 1613 Jino adults, including 762 men and 851 women, participated in this survey (haematological and demographic characteristics of the total population included in the study are given in table 1). The following haematological variables were measured: haemoglobin (Hb), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), red blood cell (RBC) and red cell distribution width (RDW). Haemoglobin was analysed by high-performance liquid chromatography (HPLC) using the Variant II haemoglobin analysing system (Bio-Rad Laboratories, Hercules, California, USA). α-and β-globin genetic testing was performed in participants (n=363) with hypochromic microcytic anaemia (MCV <80fL and/or MCH <27 pg) and/or positive HPLC profiles. In order to evaluate the validity of primary screening approaches for detection of thalassaemia carriers, we randomly selected some of the individuals with negative screening results (n=50) from the remaining participants (n=1250) for further genetic testing.
MATERIALS AND METHODS

Genetic testing
Genomic DNA was extracted from venous blood leucocytes. Three methods were used to detect thalassaemic mutations.
A CapitalBio Thalassaemia Gene Mutation Detection Kit (CapitalBio, Beijing, China) was used to determine 25 common mutations in globin genes in the Chinese population via DNA microarray. Six α-thal gene To validate β-thal mutations, three fragments of the β-globin gene were amplified. The first fragment was amplified with 5′-CCT AAG CCA GTG CCA GAA GAG C-3′ as the forward primer and 5′-TGC CCA GTT TCT ATT GGT CTC C-3′ as the reverse primer, the second fragment was amplified with 5′-TAG AAA CTG GGC ATG TGG AG-3′ as the forward primer and 5′-TGT ACC CTG TTA CTT ATC CC-3′ as the reverse primer, and the third fragment was amplified with 5′-TCA GGG CAA TAA TGA TAC AA-3′ as the forward primer and 5′-TTA GTA GTT GGA CTT AGG GA-3′ as the reverse primer. The fragments were sequenced using a 3500 Genetic Analyser (Applied Biosystems, Foster City, California, USA).
We also confirmed three α-thal deletions-that is, the Southeast Asian deletion (--SEA ), rightward deletion (-α 3.7 ) and leftward deletion (-α 4.2 )-using multiplex gap-PCR assays. Primers and PCR conditions were designed as described in the literature. 11 12 Statistical analysis A statistical analysis was carried out using SAS for Windows (V.9.2). All quantitative traits were tested for normality, and skewed quantitative traits were logarithmically transformed to approximate univariate normality. Data are shown as means±SD. Quantitative traits (RBC, Hb, MCV, MCH, RDW) were compared between two groups using the Wilcoxon test, and analysis of variance was performed to compare the differences in the three subgroups of thalassaemia carriers (α-Thal, β-Thal and αβ-Thal). Two-tailed statistical significance was considered at p<0.05.
RESULTS
Mutations identified in Jino
Owing to mutations in different globin genes, we observed three groups of thalassaemic carriers, including individuals with only α-thal gene deletions or β-thal gene mutations and individuals with combined αβ-thalassaemia (αβ-thal) gene mutations. Four different thalassaemia mutations were detected in 203 individuals among 363 suspected cases. No mutations were observed in 50 individuals with negative primary screening results. Table 2 shows the allele frequency of α-and β-thal mutations found in our study.
Mutations in the α-thal gene None of the three common non-deletional α + -thal mutations, Hb Constant Spring (HBA2:c.427T>C), Hb Quong , the α-globin chain is totally deleted; α + , the α-globin chain is partly deleted; β A , the normal β-globin chain; β E , the abnormal β-globin chain of HbE mutation; β 0 , the β-globin chain is totally deleted. 
Haematological features of different thalassaemia genotypes
The haematological data of different thalassaemia genotypes are summarised in table 3. Compared with normal individuals, thalassaemic carriers had significantly lower Hb, MCV and MCH levels ( p<0.001, respectively) and higher RBC and RDW levels ( p<0.001, respectively). Furthermore, we compared the differences in these five indexes among the three groups of carriers (α-thal, β-thal and αβ-thal). Significant differences in MCV ( p=0.0111), MCH ( p=0.0002) and RBC ( p=0.0012) were observed between these groups. MCV and MCH levels in the α-thal group were significantly lower than those in the β-thal group ( p<0.05), whereas RBC levels were higher ( p<0.05). In contrast, no difference was observed between the αβ-thal and α-thal groups/β-thal groups. Moreover, there was a tendency towards increased RDW Figure 4 Heterozygous CD26 (G>A) mutation (A) and the corresponding normal sequence of β-globin. Red arrow indicates the position of this point mutation. levels in the α-thal group compared with the β-thal group ( p=0.0573).
DISCUSSION
Thalassaemia is a common monogenic disease with a relatively high prevalence in Southeast Asia. In China, this disease is mainly prevalent in areas near the southern bank of the Yangtze River, such as Guangdong, Guangxi, Fujian and Yunnan Provinces. [13] [14] [15] Prenatal screening and related molecular diagnoses are crucial for preventing and treating thalassaemia. Many thalassaemia studies have been conducted in Yunnan Province. 16 17 However, data on the Jino population are limited because this population is the last ethnic minority confirmed in China.
We randomly selected 1613 Jino adults from eight villages around Jino Mountain in Jinghong, Southern Yunnan. Among the gene mutations identified, the most prevalent α-thal and β-thal genotypes in this region were --SEA and HbE, in agreement with previous data from Yunnan Province. 18 19 According to our results, the overall prevalence of thalassaemia in Jino was nearly 12.6%, which is similar to the prevalence observed in Kunming. 20 Prevalence of αβ-thal (8%) in our population was equal to that in the Li population in Hainan Province (7.99%), where thalassaemia prevalence is high. 21 Although Yunnan Province has a high prevalence of thalassaemia with diverse genotypes, the spectrum of globin gene mutations among the Jino population is relatively limited.
HbE, a type of haemoglobinopathy, can be observed in most regions of Southeast China. 22 Due to a point mutation in the β-globin gene, the balance of various globin products is disrupted, leading to a structural haemoglobin variant. Although HbE carriers may only have slight anaemia, their offspring will exhibit severe clinical symptoms in the presence of other β-thal types. 23 Therefore, potential HbE carriers should undergo genetic testing and prenatal counselling. HPLC is often used as an efficient primary screening method to detect abnormal Hb, as was carried out in this study and previous studies. 24 25 In our study, 95.6% (131/137) of HbE carriers were identified by HPLC, and 13 of these individuals had concomitant α-thal deletions.
Different genotypes lead to different clinical phenotypes. 26 We found that thalassaemic carriers had significantly lower MCV and MCH levels. Regarding those with β-thal mutations, MCV and MCH levels were significantly decreased in CD17 carriers compared with HbE carriers, suggesting that a nonsense mutation in the β-globin gene causes greater erythrocyte impairment. Hypochromic microcytic anaemia was moderate in individuals with β E /β A and α + /α compared with β E /β A carriers. This paradox may be explained by the fact that changes in the α-and β-globin chains may balance each other out when both mutations coexist in an individual. Accordingly, rapidly estimating the genetic state of an illness based on haematological variables is difficult. Therefore, genetic screening of both α-and β-globin gene mutations in potential parents is of utmost importance to prevent births with severe defects. 27 However, there are some limitations in this study. First, the sample size we used in the genetic testing was relatively small and may not have the validity to identify the rare thalassaemia variants from this ethnic group. Second, investigations of population and family structure were not performed in this study, although α-thal and β-thal gene mutations were common among the Jino ethnic minority. As a result, further studies on the inbreeding levels and consanguinity structure are warranted to reveal the underlying mechanism of gene flow and then assess the occurrence and persistence of α-thal and β-thal gene mutations, especially coexisting α-thal and β-thal gene mutations within Jino individuals.
In conclusion, this study revealed α-and β-thal mutations in the Jino ethnic minority population in Yunnan Province. Of these mutations, --SEA and HbE were the most prevalent α-thal and β-thal gene mutation types, respectively. In addition, data based on clinical haematological variable analysis indicated that the severity of hypochromic microcytic anaemia is associated with the genotype of thalassaemia. Our results provide evidence that may be useful for further genetic counselling, prenatal screening and clinical diagnosis of thalassaemia in this region.
